Adherence to national guidelines on antibiotic prescription for COPD

R. A. Heinink, T. J. Fletcher (Sutton Coldfield, Birmingham, United Kingdom)

Source: Annual Congress 2006 - COPD therapy
Session: COPD therapy
Session type: Oral Presentation
Number: 4398
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. A. Heinink, T. J. Fletcher (Sutton Coldfield, Birmingham, United Kingdom). Adherence to national guidelines on antibiotic prescription for COPD. Eur Respir J 2006; 28: Suppl. 50, 4398

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adherence to national (UK) respiratory guidelines in general practice
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007



Monitoring of COPD. A review of current guidelines‘ recommendations
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007



Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 903-908
Year: 2001



The hospital management of COPD exacerbations in the UK: does it conform to national guidance?
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Antibiotic treatment in pneumonia and chronic obstructive pulmonary disease – adherence to guidelines in an English teaching hospital
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Antibiotic treatment and prophylaxis
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006


Patient adherence with COPD therapy
Source: Eur Respir Rev 2005; 14: 97-101
Year: 2005



Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


Antibiotic effectiveness to prevent new chronic obstructive pulmonary disease (COPD) exacerbations in current medical practice
Source: Annual Congress 2009 - Functional insights into COPD
Year: 2009


Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010



Compliance with physical activity guidelines in COPD
Source: Annual Congress 2007 - Rehabilitation: measuring, monitoring and maintenance
Year: 2007


Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009



Why short-term antibiotic use in AECB may influence long-term outcomes
Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI
Year: 2005

Poor compliance with guidelines for prescription of long-term oxygen therapy (LTOT) in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - Palliative care, oxygen and community care for chronic lung disease
Year: 2010


Modern treatment of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 60S-66S
Year: 2001



Drug prescribing and burden of asthma and chronic obstructive pulmonary disease (COPD): a study from Italian general practitioners
Source: Eur Respir J 2005; 26: Suppl. 49, 672s
Year: 2005

Predictors of adherence to an outpatient pulmonary rehabiliation program
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Bacteria, antibiotics and COPD
Source: Eur Respir J 2001; 17: 995-1007
Year: 2001



Self-management plans in exacerbations of COPD
Source: Annual Congress 2006 - Exacerbation of COPD
Year: 2006